Showing results (71-80 of 358) with videos related to
Sort By:
Pageof 36
Pain|August 1, 1993
Characteristics of chronic pain patients: factor analysis of the MMPI-2William W Deardorff, Allan F Chino, David W ScottPain|April 1, 1991
Comprehensive multidisciplinary treatment of chronic pain: a follow-up study of treated and non-treated groupsWilliam W Deardorff, Howard S Rubin, David W ScottJournal of the American Heart Association|August 1, 2013
Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of originDavid W Scott, Matthew O Vallejo, Rakesh P PatelJournal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathwayYan Su, Gregory Carey, Maja Maric, et al.Blood|March 19, 2013
Progress toward inducing immunologic tolerance to factor VIIIDavid W Scott, Kathleen P Pratt, Carol H MiaoInternational Immunology|July 4, 2002
In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragmentMoustapha el-Amine, Jennifer A Hinshaw, David W ScottSeminars in Hematology|December 27, 2023
Biological heterogeneity in diffuse large B-cell lymphomaLaura K Hilton, David W Scott, Ryan D MorinCell Reports|June 28, 2016
A c-Myc/miR17-92/Pten Axis Controls PI3K-Mediated Positive and Negative Selection in B Cell Development and Reconstitutes CD19 DeficiencyDavid Benhamou, Verena Labi, Rostislav Novak, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2010
B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cellsJonathan Skupsky, Ai-Hong Zhang, Yan Su, et al.Human Gene Therapy|July 24, 2010
Gene therapy with IgG-HY fusion proteins to reduce male-specific T-cell reactivity in vitroMiranda P Dierselhuis, Ellen Schrama, David W Scott, et al.Pageof 36